Last updated on February 2018

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency


Brief description of study

To evaluate the safety and efficacy of PEG Somatropin Injection in the treatment of children with growth hormone deficiency, as well as to study the feasibility of extending the dosing intervals (once per two weeks) of PEG Somatropin Injection.

Clinical Study Identifier: NCT02976675

Find a site near you

Start Over